NIDA Mentored Training Award

Become a Future Leader in Substance Use Disorder Treatment

NIDA Image

As substance use disorder (SUD) continues to be a pressing issue for health care providers, NPs are often on the front lines of SUD treatment and research. Continue to develop your expertise in SUD and share your research findings via this grant award made available through a collaboration with the National Institute on Drug Abuse (NIDA).

NIDA Mentored Training Award in Substance Use Disorder (SUD) Treatment Science

The purpose of this award is to enhance your ability to disseminate the clinical knowledge of SUD management gained via a mentored project experience. Aimed at either dissemination or adoption of evidence-based SUD treatment practices, this project will:

  • Provide a mentored experience that eventually fosters interest in either a clinical career providing evidence-based management of SUD in medical settings or potentially stimulates interest in securing a NIH career development or other grant award to pursue implementation and related research in the field of substance misuse and SUD in subsequent years.
  • Provide a mentored experience in effective dissemination of existing or emerging research findings or the implementation and adoption of research in clinical practice. Applicants are encouraged to develop projects that address or improve upon current gaps in the dissemination of research findings or implementation and adoption of evidence-based treatment practices.
  • Link the applicant with an experienced mentor to guide and facilitate an up to one year-long mentored experience, culminating in a project related to dissemination and adoption of SUD research findings.
  • Provide a mentored opportunity to learn about key areas of SUD and SUD treatment strategies through systematic literature review, attendance at conferences and workshops and interaction with leading experts in the field.

Up to two grants of $10,000 ($10,000 to applicant, $2,000 stipend to mentor) will be awarded for the year 2019. The funding cycle begins January 2019 and ends December 2019—projects must be completed and reports must be submitted by December 31, 2019. Awards will be disbursed in three equal payments after the proposal is accepted and the required progress reports are received.

The application period closed at midnight October 17, 2018.

Eligibility Requirements

Applicants must:

  • Be a current AANP member who is certified, is licensed and is early in his or her SUD career (less than five years’ experience).
  • Have an established mentor with experience in SUD treatment or research.
  • Must not have a current or previous significant, individual project funding in the SUD field.

Program Requirements

All discoveries resulting from work supported in part by the NIDA Award should be made available to the public and scientific community through approved scientific channels, such as national meetings and peer-reviewed publications.

As such, awardees will be required to attend the 2020 AANP National Conference to present a poster abstract of their work following the completion of the award. Awardees will also attend the 2019 or 2020 NIDA Clinical Trials Network Annual Steering Committee Meeting, date and location to be announced.

If your project is published, publications should acknowledge the support of NIDA and AANP. Two reprints of each publication should be forwarded to AANP and NIDA.

All applicants are responsible for ensuring their own adherence to all federal research regulations, certifications and assurances. Institutional agreement of acceptance of their role and responsibility for the oversight of the award and proposed activities will be requested through the application process.

Recipients will be contacted annually by the NIDA Blending Initiative following completion of the funding year regarding career paths, ongoing dissemination or implementation activities, leadership in promoting the adoption of evidence-based practices in clinical settings, subsequent grants or contracts obtained and publications.

Awardees will be responsible for submitting:

  • Six-month narrative progress report: June 28, 2019
  • Final narrative report at the end of funding cycle: December 28, 2019

Types of Projects Accepted

Projects include but are not limited to:

  • Reviewing available curricula or training programs; identifying status of education on SUD, especially opioid use disorder (OUD), OUD diagnosis and management in various settings; and proposing and conducting activities to improve or increase the adoption of evidence-based practice.
  • Developing materials that could be used for quality improvement or integration of an evidence-based approach or process in the management of SUD, including OUD, in a medical setting and conducting activities for quality improvement or adoption.
  • Identifying training gaps and research findings or products developed by NIDA, other federal agencies or professional associations that could bridge gaps; identifying potential partners for effective dissemination of these findings; and disseminating them within existing or newly developed communication channels.
  • Other activities consistent with the goals of the NIDA CTN Dissemination Initiative to accelerate the dissemination of research findings and implementation or adoption of evidence-based SUD treatment in clinical practice.
  • Analysis of de-identified data from completed clinical trials, such as those found on the NIDA Data Share website, to inform dissemination or implementation efforts, to characterize availability of data on substance use or practice patterns, to identify gaps in the provision of evidence-based practices or to identify needs for dissemination or implementation.

This award cannot support new, free-standing pilot studies, clinical trials or clinical research studies. Any proposed activities, such as secondary analyses or quality improvement initiatives, must be eligible for IRB exemption.

?>